Satoshi Harada

About

Dr. Satoshi Harada is a urologic oncologist whose research focuses on refining risk stratification and surgical outcomes in prostate cancer. His work centers on the critical interplay between biopsy Gleason scoring and pathological findings, particularly in patients with intermediate- to high-risk disease. Dr. Harada’s most cited study (2021, 5 citations) investigates predictive factors for pathological downgrading after prostatectomy in men with biopsy Gleason score 4+3 or 4+4, demonstrating that the proportion of Gleason pattern 4 at biopsy significantly impacts risk classification. This insight helps clinicians better counsel patients on prognosis and treatment planning. He has also contributed to the characterization of rare renal tumors, such as 6p.21 translocation renal cell carcinoma in the elderly, distinguishing its radiological features from fat-poor angiomyolipoma. Most recently (2025), Dr. Harada has advanced nerve-sparing robotic-assisted radical prostatectomy techniques, showing that omitting nerve-sparing in the peripheral zone is safe when PI-RADS ≥3 lesions or Gleason pattern ≥4 are absent. His work bridges pathology, imaging, and surgical precision, offering practical guidance for personalized prostate cancer care.

Research Focus

Key Achievements

Top Papers

1. 1
   The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer

   5 citations · 2021
2. 2
   6p.21 translocation renal cell carcinoma in the elderly: radiological findings mimicking fat poor angiomyolipoma or papillary renal cell carcinoma

   2 citations · 2021
3. 3
   Nerve-Sparing Robotic-Assisted Radical Prostatectomy Based on the Absence of Prostate Imaging-Reporting and Data System ≥3 or Biopsy Gleason Pattern ≥4 in the Peripheral Zone

   1 citations · 2025

Key Collaborators

Contact & Links